Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 46, 2014 - Issue 1: Psychedelic Resurgence—Research and Therapeutic Uses, Past and Present
Submit an article Journal homepage
2,375
Views
27
CrossRef citations to date
0
Altmetric
Original Articles

From Hofmann to the Haight Ashbury, and into the Future: The Past and Potential of Lysergic Acid Diethlyamide

David E. SmithDavid E. Smith, M.D. & Associates, San Francisco, CACorrespondence[email protected]
, M.D. , F.A.S.A.M. , F.A.A.C.T.,
Glenn E. RaswyckDavid E. Smith, M.D. & Associates, San Francisco, CA
, E.M.T. &
Leigh Dickerson DavidsonDavid E. Smith, M.D. & Associates, San Francisco, CA
, A.B.
Pages 3-10 | Published online: 11 Mar 2014

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Joshua Falcon. (2021) Consciousness as a domain of extraterritoriality. Culture, Theory and Critique 62:1-2, pages 56-75.
Read now
Tamonud Modak, Roshan Bhad & Ravindra Rao. (2019) A rare case of physical dependence with psychedelic LSD - A case report. Journal of Substance Use 24:4, pages 347-349.
Read now
Logan Neitzke-Spruill & Carol Glasser. (2018) A Gratuitous Grace: The Influence of Religious Set and Intent on the Psychedelic Experience. Journal of Psychoactive Drugs 50:4, pages 314-321.
Read now

Articles from other publishers (24)

Burton J. TabaacKenneth Shinozuka, Alejandro ArenasBryce D. BeutlerKirsten CherianViviana D. EvansChelsey FasanoOwen S. Muir. (2024) Psychedelic Therapy: A Primer for Primary Care Clinicians—Historical Perspective and Overview. American Journal of Therapeutics 31:2, pages e97-e103.
Crossref
Amy L Patton, Jordan Brown, Kimberley Heine, David A Sartori, Erin L Karschner & Jeffrey P Walterscheid. (2023) Quantitative Analysis of Lysergic Acid Diethylamide and Metabolite in Urine by Automated Extraction and Liquid Chromatography–Tandem Mass Spectrometry. Journal of Analytical Toxicology 47:5, pages 448-454.
Crossref
Marija Franka Žuljević, Ivan Buljan, Mia Leskur, Mariano Kaliterna, Darko Hren & Darko Duplančić. (2022) Validation of a new instrument for assessing attitudes on psychedelics in the general population. Scientific Reports 12:1.
Crossref
Michał K. Jastrzębski, Agnieszka A. Kaczor & Tomasz M. Wróbel. (2022) Methods of Lysergic Acid Synthesis—The Key Ergot Alkaloid. Molecules 27:21, pages 7322.
Crossref
Phoebe Friesen. (2022) Psychosis and psychedelics: Historical entanglements and contemporary contrasts. Transcultural Psychiatry 59:5, pages 592-609.
Crossref
Kristin Waters. (2021) Pharmacologic Similarities and Differences Among Hallucinogens. The Journal of Clinical Pharmacology 61:S2.
Crossref
Nicholas M. Barnes, Gerard P. Ahern, Carine Becamel, Joël Bockaert, Michael Camilleri, Severine Chaumont-Dubel, Sylvie Claeysen, Kathryn A. Cunningham, Kevin C. Fone, Michael Gershon, Giuseppe Di Giovanni, Nathalie M. Goodfellow, Adam L. Halberstadt, Rachel M. Hartley, Ghérici Hassaine, Katharine Herrick-Davis, Ruud Hovius, Enza Lacivita, Evelyn K. Lambe, Marcello Leopoldo, Finn Olav Levy, Sarah C. R. Lummis, Philippe Marin, Luc Maroteaux, Andrew C. McCreary, David L. Nelson, John F. Neumaier, Adrian Newman-Tancredi, Hugues Nury, Alexander Roberts, Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. Villalón, Horst Vogel, Stephanie W. Watts & Daniel Hoyer. (2020) International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacological Reviews 73:1, pages 310-520.
Crossref
Victor Distefano Wiltenburg, Dianne da Rocha Prado & Fúlvio Rieli Mendes. 2021. Drugs and Human Behavior. Drugs and Human Behavior 479 510 .
Kristóf János Bodnár & Péter Kakuk. (2018) Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review. Medicine, Health Care and Philosophy 22:2, pages 327-337.
Crossref
Gareth J Parry & Eric J Buenz. (2018) Adventures in self experimentation. BMJ, pages k5006.
Crossref
Susan Schenk & David Newcombe. (2018) Methylenedioxymethamphetamine (MDMA) in Psychiatry. Journal of Clinical Psychopharmacology 38:6, pages 632-638.
Crossref
Eduardo Ekman Schenberg. (2018) Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development. Frontiers in Pharmacology 9.
Crossref
Ben Sessa. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen 83 104 .
Daniel Martins, Monica J. Barratt, Cristiana Vale Pires, Helena Carvalho, Mireia Ventura Vilamala, Iván Fornís Espinosa & Helena Valente. (2017) The detection and prevention of unintentional consumption of DOx and 25x‐NBOMe at Portugal's Boom Festival. Human Psychopharmacology: Clinical and Experimental 32:3.
Crossref
Rafael G. dos Santos, José Carlos Bouso & Jaime E. C. Hallak. (2017) Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Therapeutic Advances in Psychopharmacology 7:4, pages 141-157.
Crossref
Ben Sessa. 2017. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen 1 29 .
Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Alexander Stratford, Simon P. Elliott, Khoa Hoang, Jason Wallach & Adam L. Halberstadt. (2015) Return of the lysergamides. Part I: Analytical and behavioural characterization of 1‐propionyl‐ d ‐lysergic acid diethylamide (1P‐LSD) . Drug Testing and Analysis 8:9, pages 891-902.
Crossref
Rafael G. dos Santos, Flávia L. Osório, José Alexandre S. Crippa, Jordi Riba, Antônio W. Zuardi & Jaime E. C. Hallak. (2016) Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology 6:3, pages 193-213.
Crossref
Jens Knud Larsen. (2016) Neurotoxicity and LSD treatment: a follow-up study of 151 patients in Denmark. History of Psychiatry 27:2, pages 172-189.
Crossref
Stephanie M Woo & Carolyn Keatinge. 2016. Diagnosis and Treatment of Mental Disorders Across the Lifespan. Diagnosis and Treatment of Mental Disorders Across the Lifespan 957 1168 .
Colin Davidson & Fabrizio Schifano. (2016) The potential utility of some legal highs in CNS disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, pages 267-274.
Crossref
Ben Sessa. 2016. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen 1 26 .
Ana Margarida Araújo, Félix Carvalho, Maria de Lourdes Bastos, Paula Guedes de Pinho & Márcia Carvalho. (2015) The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology 89:8, pages 1151-1173.
Crossref
Adam Michael Stewart, Ester Yang, Michael Nguyen & Allan V. Kalueff. (2014) Developing zebrafish models relevant to PTSD and other trauma- and stressor-related disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 55, pages 67-79.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.